Proposed policy boosts for robotics, EVs, Ayurveda and MSME finance in 2027‑28
Esocam, a leading industry forum, has presented a slate of policy proposals for the Union Budget 2027‑28 that aim to strengthen robotics manufacturing, electric‑vehicle adoption, traditional health sectors and MSME financing.
The centerpiece of the recommendation is a new Production‑Linked Incentive programme tailored specifically for robotics, automation gear, sensors and precision parts. Esocam argues that such a targeted PLI will catalyse domestic output, spur R&D activities, attract capital investment and position India as a global hub for advanced manufacturing.
Complementary to the robotics push, the body stresses the importance of uplifting other high‑potential segments—specialty steel, textiles, white‑goods, ACC battery cells and solar PV modules. It calls for simplified compliance, timely release of incentive funds and strict monitoring to ensure effective rollout.
On the innovation front, Esocam urges the re‑introduction of R&D tax incentives that previously delivered tangible results. The suggested measures cover a 200 percent weighted deduction on eligible research spend, a complete 100 percent deduction on qualifying capital expenditure, customs duty exemptions on scientific equipment, accelerated depreciation and tax holidays for certified research enterprises. Restoring these benefits, the organization contends, will revitalize the country’s innovation engine.
For the electric‑vehicle ecosystem, Esocam proposes that EVs be permitted to register and obtain financing without a battery pack, easing market entry. Additionally, it recommends a 3 percent interest subsidy for MSME fleet operators and an extension of loan tenures to seven or eight years, aligning financing terms with battery warranty periods.
Addressing the traditional health industry, Esocam calls for a joint government‑industry clinical research programme focused on Ayurveda and AYUSH products. The initiative would provide grants and financial support, bolstering scientific validation and expanding the reach of Indian traditional medicines in global markets.
